While serum biomarkers like angiotensin-converting enzyme (ACE) and imaging studies such as chest X-rays are valuable in diagnosing systemic sarcoidosis, their utility in neurosarcoidosis is limited [4]. This evidence concerns the gene ACE and neurosarcoidosis.